Baricitinib set to join the Covid-19 therapeutic arsenal?
Rheumatology (Oxford)
; 60(4): 1585-1587, 2021 04 06.
Article
in En
| MEDLINE
| ID: mdl-33502499
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purines
/
Pyrazoles
/
Sulfonamides
/
Azetidines
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2021
Document type:
Article
Country of publication:
United kingdom